Advances and thoughts in traditional Chinese medicine diagnosis and treatment of chronic hepatitis B-related liver fibrosis
10.3969/j.issn.1001-5256.2023.02.002
- VernacularTitle:慢性乙型肝炎相关肝纤维化中医诊疗进展与思考
- Author:
Huanming XIAO
1
,
2
;
Meijie SHI
1
,
2
;
Yubao XIE
1
,
2
;
Xiaoling CHI
1
,
2
Author Information
1. Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China
2. The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
- Publication Type:Discussions by Experts
- Keywords:
Hepatitis B, Chronic;
Liver Fibrosis;
Diagnosis;
Therapeutics;
Medicine, Chinese Traditional
- From:
Journal of Clinical Hepatology
2023;39(2):260-266
- CountryChina
- Language:Chinese
-
Abstract:
Liver fibrosis is a necessary intermediate process from the progression of chronic hepatitis B to liver cirrhosis and liver cancer. In recent years, breakthroughs have been made in the research on traditional Chinese medicine (TCM) for the prevention and treatment of chronic hepatitis B liver fibrosis. For the purpose of improving clinical outcome, multidisciplinary industry-university-research studies are conducted to explain the biological basis of TCM syndromes of chronic hepatitis B liver fibrosis, and establishment and development of a non-invasive diagnostic model with TCM characteristics, optimization of TCM/integrated traditional Chinese and Western medicine treatment regimens, and elaboration on the scientific connotation of TCM treatment can help TCM for the prevention and treatment of liver fibrosis to enter the global world.
